Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...

Bristol-Myers Squibb beat Q4 earnings expectations, but the stock fell due to lowered 2025 revenue guidance and patent ...

In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Bristol-Myers Squibb (BMY – Research Report).

President Trump’s statements and actions include posts on Truth Social about balancing the budget, a return to plastic straws ...

The stock market was up and down with Trump tariff fears in focus. Palantir led big earnings winners. Google and Amazon were ...